Statins may help prevent diabetes-related eye problems
(Reuters Health) - Diabetic patients who take statins to treat high cholesterol may get an added benefit: a lower risk of damage to the retina, a new study suggests.
A new study aims to elucidate the link between PCSK9 inhibitors and glucose metabolism. Might they increase the risk of diabetes, as statins have been shown to do?European Heart Journal
CONCLUSION: Measurement of serum anti-apo B-100 autoantibodies can be useful for the evaluation of CVD risk in patients with diabetes receiving statin treatment. PMID: 30867375 [PubMed - as supplied by publisher]
AbstractBackground and AimWe identified patients without medical record evidence of up-to-date colorectal cancer (CRC) screening and sent an invitation letter to self-schedule a colonoscopy without requiring prior primary care or gastroenterologist consultation. The aim of the study was to evaluate the response rate to the letter and factors associated with colonoscopy completion.MethodsA computer algorithm invited patients not up to date with CRC screening, with an INR
Abstract Lower extremity peripheral artery disease (PAD) affects 12% to 20% of Americans 60 years and older. The most significant risk factors for PAD are hyperlipidemia, hypertension, diabetes mellitus, chronic kidney disease, and smoking; the presence of three or more factors confers a 10-fold increase in PAD risk. Intermittent claudication is the hallmark of atherosclerotic lower extremity PAD, but only about 10% of patients with PAD experience intermittent claudication. A variety of leg symptoms that differ from classic claudication affects 50% of patients, and 40% have no leg symptoms at all. Current guidelin...
This article is protected by copyright. All rights reserved. PMID: 30869158 [PubMed - as supplied by publisher]
Diabetes mellitus increases the risk of tuberculosis (TB) disease and adverse TB outcomes . Emerging evidence suggests diabetes is also associated with latent TB infection (LTBI), and population-based studies reported the prevalence of LTBI among US adults with diabetes to be more than twice that of adults without diabetes (11.6% versus 4.6%) [2, 3]. Given the rapid increase of global diabetes prevalence in regions with high TB burdens, clinical and public health interventions targeting this co-epidemic would avert substantial morbidity and mortality .
Risk was greater among people who were overweight, obese or who had prediabetes, prompting calls for lifestyle intervention when starting patients on statins.Medscape Medical News
Authors: Khalil S, Khayyat S, Al-Khadra Y, Alraies MC PMID: 30856356 [PubMed - as supplied by publisher]
Journal Name: Journal of Pediatric Endocrinology and Metabolism Issue: Ahead of print
Conclusion The results of this study support the preferential prescription of moderate-intensity rosuvastatin over moderate-intensity atorvastatin for the secondary prevention of ischemic cardiovascular and cerebrovascular events in older patients aged ≥ 75 years.